Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Rationale and Design of Sympathetic Mapping/Ablation of Renal Nerves Trial (SMART) for the Treatment of Hypertension: a Prospective, Multicenter, Single-Blind, Randomized and Sham Procedure-Controlled Study.Journal of cardiovascular translational research · 2023
   Article
2. Acute changes in morphology and renal vascular relaxation function after renal denervation using temperature-controlled radiofrequency catheter.BMC cardiovascular disorders · 2019
   Article
3. A Perspective on the Delivery of Renal Denervation Therapy Based on Pre-Clinical Data.JACC. Basic to translational science · 2016
   Review
4. The rise, fall, and possible resurrection of renal denervation.Nature reviews. Cardiology · 2016
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as